These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26314580)

  • 41. The T687G SNP in a P-glycoprotein gene of Fasciola hepatica is not associated with resistance to triclabendazole in two resistant Australian populations.
    Elliott TP; Spithill TW
    Mol Biochem Parasitol; 2014 Nov; 198(1):45-7. PubMed ID: 25481750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of putative markers of triclabendazole resistance by a genome-wide analysis of genetically recombinant Fasciola hepatica.
    Hodgkinson J; Cwiklinski K; Beesley NJ; Paterson S; Williams DJ
    Parasitology; 2013 Oct; 140(12):1523-33. PubMed ID: 23721579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
    Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland.
    Mooney L; Good B; Hanrahan JP; Mulcahy G; de Waal T
    Vet Parasitol; 2009 Oct; 164(2-4):201-5. PubMed ID: 19556063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica.
    Gordon DK; Zadoks RN; Stevenson H; Sargison ND; Skuce PJ
    Vet Parasitol; 2012 Jul; 187(3-4):436-44. PubMed ID: 22421492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2014 Jul; 141(8):1064-79. PubMed ID: 24889697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica.
    Chemale G; Perally S; LaCourse EJ; Prescott MC; Jones LM; Ward D; Meaney M; Hoey E; Brennan GP; Fairweather I; Trudgett A; Brophy PM
    J Proteome Res; 2010 Oct; 9(10):4940-51. PubMed ID: 20726552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica.
    Davis CN; Winters A; Milic I; Devitt A; Cookson A; Brophy PM; Morphew RM
    Sci Rep; 2020 Aug; 10(1):13445. PubMed ID: 32778698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early onset of changes to the reproductive system of Fasciola hepatica following in vivo treatment with triclabendazole.
    Hanna RE; Scarcella S; Solana H; McConnell S; Fairweather I
    Vet Parasitol; 2012 Mar; 184(2-4):341-7. PubMed ID: 21944196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pilot Evaluation of Two
    Collett CF; Morphew RM; Timson D; Phillips HC; Brophy PM
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751696
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testing albendazole resistance in Fasciola hepatica: validation of an egg hatch test with isolates from South America and the United Kingdom.
    Canevari J; Ceballos L; Sanabria R; Romero J; Olaechea F; Ortiz P; Cabrera M; Gayo V; Fairweather I; Lanusse C; Alvarez L
    J Helminthol; 2014 Sep; 88(3):286-92. PubMed ID: 23510506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variability of the egg hatch assay to survey benzimidazole resistance in nematodes of small ruminants under field conditions.
    Calvete C; Ferrer LM; Lacasta D; Calavia R; Ramos JJ; Ruiz-de-Arkaute M; Uriarte J
    Vet Parasitol; 2014 Jun; 203(1-2):102-13. PubMed ID: 24702769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 Jul; 107(2):337-53. PubMed ID: 20512589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica.
    Fetterer RH
    J Vet Pharmacol Ther; 1986 Mar; 9(1):49-54. PubMed ID: 3701915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Vet Parasitol; 2013 Jul; 195(1-2):72-86. PubMed ID: 23597772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of egg production by triclabendazole-resistant Fasciola hepatica following treatment with a commercial preparation of myrrh (Mirazid).
    Abdelaal MMO; Brennan GP; Hanna REB; Abdel-Aziz A; Fairweather I
    Acta Parasitol; 2017 Jun; 62(2):336-347. PubMed ID: 28426420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triclabendazole-resistant liver fluke in Scottish sheep.
    Mitchell GB; Maris L; Bonniwell MA
    Vet Rec; 1998 Oct; 143(14):399. PubMed ID: 9802201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.